A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
Open Access
- 8 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in npj Vaccines
- Vol. 6 (1), 1-12
- https://doi.org/10.1038/s41541-021-00284-w
Abstract
Nipah and Hendra viruses are highly pathogenic bat-borne paramyxoviruses recently included in the WHO Blueprint priority diseases list. A fully registered horse anti-Hendra virus subunit vaccine has been in use in Australia since 2012. Based on the same immunogen, the Hendra virus attachment glycoprotein ectodomain, a subunit vaccine formulation for use in people is now in a Phase I clinical trial. We report that a single dose vaccination regimen of this human vaccine formulation protects against otherwise lethal challenges of either Hendra or Nipah virus in a nonhuman primate model. The protection against the Nipah Bangladesh strain begins as soon as 7 days post immunization with low dose of 0.1 mg protein subunit. Our data suggest this human vaccine could be utilized as efficient emergency vaccine to disrupt potential spreading of Nipah disease in an outbreak setting.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI098760, R01AI098760)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
This publication has 34 references indexed in Scilit:
- Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 monthsVirology Journal, 2013
- Nipah Virus Infection Outbreak with Nosocomial and Corpse-to-Human Transmission, BangladeshEmerging Infectious Diseases, 2013
- A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus ChallengeScience Translational Medicine, 2012
- Henipavirus outbreaks to antivirals: the current status of potential therapeuticsCurrent Opinion in Virology, 2012
- Pathology of Acute Henipavirus Infection in Humans and AnimalsPathology Research International, 2011
- A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challengeVaccine, 2011
- A Novel Model of Lethal Hendra Virus Infection in African Green Monkeys and the Effectiveness of Ribavirin TreatmentJournal of Virology, 2010
- Development of an Acute and Highly Pathogenic Nonhuman Primate Model of Nipah Virus InfectionPLOS ONE, 2010
- Human Hendra Virus Encephalitis Associated with Equine Outbreak, Australia, 2008Emerging Infectious Diseases, 2010
- Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit VaccineJournal of Virology, 2006